Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis

Autor: Muneyyirci-Delale, Ozgul, Archer, David F., Owens, Charlotte D., Barnhart, Kurt T., Bradley, Linda D., Feinberg, Eve, Gillispie, Veronica, Hurtado, Sandra, Kim, Jin Hee, Wang, Alice, Wang, Hui, Stewart, Elizabeth A.
Zdroj: F&S Reports; September 2021, Vol. 2 Issue: 3 p338-346, 9p
Abstrakt: To determine if coexisting adenomyosis limits the efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy in reducing heavy menstrual bleeding in women with uterine fibroids.
Databáze: Supplemental Index